stockrow
Friday 6 November 2026
Export RGC’s income statement to Excel — free account
Regencell Bioscience Holdings Limited
RGC Healthcare Drug Manufacturers Specialty & Generic
5.26
0.01
−0.19%
Follow RGC
Alert me
Regencell Bioscience Holdings Limited (RGC) Free cash flow
Regencell Bioscience Holdings Limited's free cash flow for fiscal 2026 was −$7.7M, compared with −$3.3M in fiscal 2025. Over the past ten years it has ranged from −$7.7M (fiscal 2026) to −$391.0K (fiscal 2019) — the current reading is the lowest in ten years. Regencell Bioscience Holdings Limited ranks 64th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2026 | −$7.7M | — |
| FY2025 | −$3.3M | — |
| FY2024 | −$4.0M | — |
| FY2023 | −$5.0M | — |
| FY2022 | −$6.0M | — |
| FY2021 | −$767.3K | — |
| FY2020 | −$844.4K | — |
| FY2019 | −$391.0K | — |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Dec 2025 | −$2.6M | — |
| Jun 2025 | −$3.3M | — |
| Jun 2024 | −$4.0M | — |
| Jun 2023 | −$5.0M | — |
| 5 more quarters | Free account |
Against its own ten years
Low −$7.7M
High −$391.0K
Ten-year median
−$3.6M
Current reading's percentile
13
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. compare | $366.4M |
| TRLV Trulieve Cannabis Corp. compare | $242.5M |
| PBH Prestige Consumer Healthcare Inc. compare | $214.2M |
| PRGO Perrigo Company plc compare | $168.2M |
| XERS Xeris Biopharma Holdings, Inc. compare | $73.6M |
| RGC Regencell Bioscience Holdings Limited | −$14.7M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$130.7M |
| HCM HUTCHMED (China) Limited Sponsored ADR compare | −$171.8M |
| ALVO Alvotech compare | −$211.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)